CRP and cancer: In a recent meta-analysis pooling 83,995 participants from 14 studies, elevated CRP using a highly sensitive test has been shown as an independent predictive biomarker of mortality both for all causes with pooled RR at 1.75 (95 CI 1.55–198) and for cancer mortality, particularly in men, with pooled RR at 1.25 (CI 1.13–138) (79).